Trial Profile
Randomized Controlled Trial of The Safety and Efficacy of Aripiprazole VS Ziprasidone in Schizophrenic Patients With Metabolic Syndrome and Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Aripiprazole
- Indications Schizophrenia
- Focus Therapeutic Use
- 03 Dec 2012 New trial record